Mimedx (MDXG) Convertible Debt (2011 - 2012)
Mimedx's (MDXG) quarterly Convertible Debt came in at $4.0 million in Q4 2012, up 46.19% year-over-year from $2.7 million in Q1 2012, and up 14.85% quarter-over-quarter from $3.5 million in Q3 2012.
Powered by 
Analysis
Mimedx (MDXG) Convertible Debt (2011 - 2012) Analysis & Trends
Mimedx has disclosed Convertible Debt across 2 years of filings, most recently posting $4.0 million for Q4 2012.
- In Q4 2012, Convertible Debt rose 46.19% year-over-year to $4.0 million; the TTM figure through Dec 2012 stood at $4.0 million (up 46.19% YoY), while the FY2012 annual figure was $4.0 million, up 46.19% from the prior year.
- Convertible Debt came in at $4.0 million for Q4 2012 at Mimedx, up from $3.5 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $4.0 million in Q4 2012 to a low of $959209.0 in Q2 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn |
| 10 | Mimedx | 667.30 Mn | 531.46 Mn | 44.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | 4.01 Mn |
| Sep 30, 2012 | 3.49 Mn |
| Jun 30, 2012 | 3.24 Mn |
| Mar 31, 2012 | 3.02 Mn |
| Dec 31, 2011 | 2.74 Mn |
| Jun 30, 2011 | 959,209.00 |